Matches in Nanopublications for { ?s ?p "[This study aims to identify signatures of miR associated with hereditary, BRCA1 or BRCA2 mutation positive breast cancer (BC), and non-hereditary BC, either sporadic (SBC) or non-informative (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[This study aims to identify signatures of miR associated with hereditary, BRCA1 or BRCA2 mutation positive breast cancer (BC), and non-hereditary BC, either sporadic (SBC) or non-informative (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This study aims to identify signatures of miR associated with hereditary, BRCA1 or BRCA2 mutation positive breast cancer (BC), and non-hereditary BC, either sporadic (SBC) or non-informative (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This study aims to identify signatures of miR associated with hereditary, BRCA1 or BRCA2 mutation positive breast cancer (BC), and non-hereditary BC, either sporadic (SBC) or non-informative (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This study aims to identify signatures of miR associated with hereditary, BRCA1 or BRCA2 mutation positive breast cancer (BC), and non-hereditary BC, either sporadic (SBC) or non-informative (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1119695.RARNPRmgUln7f3ww3wSZfOFWlqlrs98s64pfi67SbdQlE130_assertion description "[This study aims to identify signatures of miR associated with hereditary, BRCA1 or BRCA2 mutation positive breast cancer (BC), and non-hereditary BC, either sporadic (SBC) or non-informative (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119695.RARNPRmgUln7f3ww3wSZfOFWlqlrs98s64pfi67SbdQlE130_provenance.
- NP1119692.RAshBTytIZuz5t21kniHs72wJmXzuqlWHhw8SOpjGetzM130_assertion description "[This study aims to identify signatures of miR associated with hereditary, BRCA1 or BRCA2 mutation positive breast cancer (BC), and non-hereditary BC, either sporadic (SBC) or non-informative (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119692.RAshBTytIZuz5t21kniHs72wJmXzuqlWHhw8SOpjGetzM130_provenance.
- NP1119693.RAMyRY7y5g3BrzpcckxfNsmGcGMzw8jp07A6y6uP5H-jE130_assertion description "[This study aims to identify signatures of miR associated with hereditary, BRCA1 or BRCA2 mutation positive breast cancer (BC), and non-hereditary BC, either sporadic (SBC) or non-informative (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119693.RAMyRY7y5g3BrzpcckxfNsmGcGMzw8jp07A6y6uP5H-jE130_provenance.
- NP1119691.RA_22fTK4inLOZGZnEB75gIHN3ditTN1X91w4d2SfDcOQ130_assertion description "[This study aims to identify signatures of miR associated with hereditary, BRCA1 or BRCA2 mutation positive breast cancer (BC), and non-hereditary BC, either sporadic (SBC) or non-informative (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119691.RA_22fTK4inLOZGZnEB75gIHN3ditTN1X91w4d2SfDcOQ130_provenance.